IDEXX Laboratories Inc.
IDXX | NASDAQ
$670.71
-$27.84 (-3.99%)
At close: Nov 5, 2026, 4:00 PM ET
$668.70
-$2.01 (-0.30%)
After-hours:
Nov 5, 2026, 4:59 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 51.37 | 38.39 | 54.58 | 50.24 | 75.34 | 73.29 |
PEG Ratio | 2.31 | 6.51 | 2.16 | -7.08 | 2.68 | 1.97 |
PS Ratio | 12.59 | 8.75 | 12.59 | 10.13 | 17.45 | 15.76 |
PB Ratio | 33.75 | 21.37 | 31.06 | 56.04 | 81.31 | 67.49 |
P/FCF Ratio | 51.44 | 42.72 | 59.65 | 86.55 | 88.21 | 78.94 |
P/OCF Ratio | 46 | 36.70 | 50.86 | 62.83 | 74.25 | 65.83 |
OCF/S Ratio | 27.37 | 23.84 | 24.76 | 16.13 | 23.50 | 23.94 |
Debt / Equity Ratio | 0.67 | 0.62 | 0.72 | 2.41 | 1.49 | 1.59 |
Quick Ratio | 0.84 | 0.95 | 1.17 | 0.59 | 0.90 | 1.46 |
Current Ratio | 1.17 | 1.31 | 1.57 | 0.89 | 1.25 | 1.82 |
Asset Turnover | 1.28 | 1.18 | 1.12 | 1.23 | 1.32 | 1.18 |
Interest Coverage | 35.54 | 36.16 | 26.39 | 22.55 | 31.27 | 20.97 |
Return on Equity | 65.99% | 55.65% | 56.92% | 111.56% | 107.95% | 92.04% |
Return on Assets | 31.62% | 26.96% | 25.92% | 24.72% | 30.56% | 25.35% |
Return on Invested Capital | 40.27% | 33.87% | 32.93% | 32.48% | 41.75% | 34.32% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 61.80% | 61.04% | 59.82% | 59.52% | 58.76% | 58.04% |
Net Profit Margin | 24.62% | 22.78% | 23.08% | 20.17% | 23.17% | 21.49% |
Pretax Profit Margin | 30.77% | 28.48% | 28.99% | 25.54% | 28.07% | 24.46% |
Operating Profit Margin | 31.60% | 28.95% | 29.97% | 26.69% | 28.99% | 25.66% |
FCF Margin | 24.48% | 20.48% | 21.11% | 11.71% | 19.78% | 19.97% |
EBITDA Margin | 35.03% | 32.73% | 33.26% | 30.13% | 32.34% | 29.33% |
Add to Watchlist
Select watchlists to add or remove IDXX